2019
DOI: 10.1038/s41467-019-09799-2
|View full text |Cite
|
Sign up to set email alerts
|

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Abstract: The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven approaches to find optimal patient-specific treatments. Here we report AstraZeneca’s large drug combination dataset, consisting of 11,576 experiments from 910 combinations across 85 molecularly characterized cancer cell lines, and results of a DREAM Challenge to evaluate computational st… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
263
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
4

Relationship

3
6

Authors

Journals

citations
Cited by 282 publications
(271 citation statements)
references
References 53 publications
8
263
0
Order By: Relevance
“…A recurrent observation across DREAM challenges is that an ensemble of individual predictions performs usually better and is more robust than any individual method [16, 17]. This phenomenon, common also in other contexts, is denoted as the wisdom-of-the-crowds (WOC) [15].…”
Section: Resultsmentioning
confidence: 99%
“…A recurrent observation across DREAM challenges is that an ensemble of individual predictions performs usually better and is more robust than any individual method [16, 17]. This phenomenon, common also in other contexts, is denoted as the wisdom-of-the-crowds (WOC) [15].…”
Section: Resultsmentioning
confidence: 99%
“…We obtained global insight into the principles and functions of interactions from analysis of the landscape, and validated new hypotheses about combinatorial cytokine effects. Developing learning models to predict synergistic combinations of treatments based on the individual effects is an active area of research [18][19][20][21] . Despite an apparent methodological similarity, the motivation and goals of our framework are fundamentally different from these studies.…”
Section: Discussionmentioning
confidence: 99%
“…To this end, several algorithms have been proposed to predict synergistic drug pairs which utilize a diverse set of features such as chemical structure, biological networks interactions (e.g., drug-protein, protein -disease, etc.) and omics data [6,7,8,9,10,11,12,13,14,15]. While feature engineering and a systems approach come with the promise of performance increase, features other than the chemical structure are not always available, and biological networks such as protein interaction networks are incomplete.…”
Section: Introductionmentioning
confidence: 99%